In development: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Expected publication date

Expected publication date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 241 to 250 of 435

TitleTypeExpected publication date
MRI-guided focused ultrasound thalamotomy for treatment-resistant essential tremorInterventional procedures guidanceTBC
MTX110 for untreated diffuse intrinsic pontine glioma [ID2695]Technology appraisal guidanceTBC
Natalizumab (originator and biosimilar) for treating highly active relapsing–remitting multiple sclerosis after disease-modifying therapy [ID6369]Technology appraisal guidanceTBC
Navepegritide for treating achondroplasia in people 2 to 15 years [ID6538]Technology appraisal guidanceTBC
Nemolizumab for treating prurigo nodularis [ID6451]Technology appraisal guidanceTBC
Neonatal infection: antibiotics for prevention and treatment - risk factors for early onset neonatal infectionNICE guideline
Nerandomilast for treating idiopathic pulmonary fibrosis or progressive pulmonary fibrosis ID6446Technology appraisal guidance
Neuro-Cells stem-cell treatment for traumatic spinal cord injury [ID6588]Technology appraisal guidanceTBC
Neuroendocrine tumours (metastatic, unresectable, progressive) - everolimus and sunitinib [ID858]Technology appraisal guidance
Nipocalimab for treating generalised myasthenia gravis [ID6562]Technology appraisal guidanceTBC

Results per page

  1. 10
  2. 25
  3. 50
  4. All